NCT05325853View on ClinicalTrials.gov

A Study of Safety and the Local Anesthetic Effect of AG-920 Ophthalmic Solution in a Pediatric Population

PHASE3CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

April 6, 2022

Primary Completion Date

May 27, 2022

Study Completion Date

May 27, 2022

Conditions
Anesthesia, Local
Interventions
DRUG

AG-920

AG-920 Sterile Topical Ophthalmic Solution

DRUG

Proparacaine Ophthalmic

0.5% Proparacaine Hydrochloride

Trial Locations (1)

78503

American Genomics Site 2, McAllen

Sponsors
All Listed Sponsors
lead

American Genomics, LLC

INDUSTRY

NCT05325853 - A Study of Safety and the Local Anesthetic Effect of AG-920 Ophthalmic Solution in a Pediatric Population | Biotech Hunter | Biotech Hunter